← All diseases
Heart and blood vessels
Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1417)
- American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging. (2024/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial for "Pulmonary Transit Time Derived from First-Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light-Chain Amyloidosis". (2024/09/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pulmonary Transit Time Derived from First-Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light-Chain Amyloidosis. (2024/09/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of transthyretin amyloidosis in patients undergoing carpal tunnel surgery: a prospective cohort study and risk factor analysis. (2024/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early Diagnosis and Treatment of Cardiac Amyloidosis by Screening Biopsy During Trigger Finger Release. (2024/08/29) ♡
- A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosis. (2024/08/23) ♡
- Erratum to Correct Errors in Text. (2024/08/02) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis. (2024/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple myeloma with secondary amyloidosis: Dysphagia as the first symptom: A case report. (2024/07/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Amyloidosis: How Its Epidemiology is Changing. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PET and Cardiac Amyloidosis: Which Possible Role? (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Amyloidosis: Role of the Endomyocardial Biopsy. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Arrhythmic Stratification of Cardiac Amyloidosis: State of the Art. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the Therapy of Light Chain Cardiac Amyloidosis. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study: Rationale and Design. (2024/07/01) ♡
- EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy. (2024/06/01) ♡
- Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy. (2024/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Clinical Utility of Computed Tomography-Derived Myocardial Extracellular Volume Fraction: A Systematic Review and Meta-Analysis. (2024/05/01) ♡
- Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis. (2024/04/21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Outcomes of Aortic Stenosis in Amyloidosis: A United States National Cohort Study. (2024/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Elevation of end-tidal CO(2) during exercise is attenuated in patients with cardiac amyloidosis. (2024/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review. (2024/04/01) ♡
- Invasive haemodynamics at rest and exercise in cardiac amyloidosis. (2024/04/01) ♡
- Real-life experience with inotersen at CEPARM, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro. (2024/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatic and cardiac shear wave elastography in the assessment of hereditary transthyretin amyloidosis. (2024/03/22) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease. (2024/03/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular Manifestations in Rheumatoid Arthritis. (2024/03/01) ♡
- Speckle tracking echocardiography in plasma cell disorders: The role of advanced imaging in the early diagnosis of AL systemic cardiac amyloidosis. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloidosis and Considerations for the Hand Surgeon. (2024/03/01) ♡
- Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy. (2024/03/01) ♡
- Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey. (2024/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Exercise Intervention for Patients With Transthyretin Amyloid Cardiomyopathy (EXCITE-ATTR-CM) Pilot Study. (2024/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Prognostic Information From Endocardial Voltage Mapping at the Time of Endomyocardial Biopsy for the Diagnosis of Cardiac Amyloidosis. (2024/03/01) ♡
- Rejection in the setting of combined Heart and Liver Transplantation. (2024/02/28) ♡
- Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease. (2024/02/15) ♡
- mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis. (2024/02/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration. (2024/02/01) ♡
- Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy. (2024/02/01) ♡
- Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis. (2024/01/20) ♡
- An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis. (2024/01/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Left bundle branch pacing in an amyloid light-chain cardiac amyloidosis patient with atrioventricular block. (2024/01/11) ♡
- Probing the Dissociation Pathway of a Kinetically Labile Transthyretin Mutant. (2024/01/10) ♡
- CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease. (2024/01/09) ♡
- Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance. (2024/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Tafamidis in Octogenarians: An ATTR-ACT-ive Choice. (2024/01/01) ♡
- Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative (99m)Tc-HDP and PYP Nuclear Scintigraphy. (2024/01/01) ♡
- Caregiver's psychological well-being and quality of relationship with cardiac amyloidosis patients. (2024/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.